m6A regulators, including METTL3, FTO, and IGF2BP2, act as tumor promoters through the C-myc pathway in an m6A-dependent manner to promote the growth, invasion, migration, and progression of various tumors, such as BC, lung cancer, and GC [109,282,283]. This evidence concerns the gene IGF2BP2 and lung cancer.